D10 Set to Celebrate 10 Years of Fundraising for Pediatric Cancer Research

The D10 is a Wall Street decathlon that has raised more than $10 million for pediatric cancer research over the years. This June, the event will celebrate it's 10th anniversary! Dave Maloney is the founder of D10. Maloney joins Cheddar to explain why the event has continued to be popular and well attended. Maloney illustrates how the event is as fun as it is beneficial. Participants enjoy a serious physical challenge, all the while, raising serious cash for pediatric cancer research. Maloney is also the founder of NORMA, a streaming software initially developed for The D10. The software enables viewers to select the athletes and events they want to watch live.

More In Business

Big Business This Week: Is the Coming IPO Wave a Financial Trap?

Do the numbers add up?

SpaceX Takes Center Stage as Wall Street Eyes the Next Big Market Catalyst

Phil Rosen, Chief Market Strategist at ProCap Financial, discusses the growing anticipation around a SpaceX IPO and Oracle's AI-driven growth.

The Race to Build America’s Drone Delivery Network Is Officially Underway

Matternet CEO Andreas Raptopoulos discusses the future of drone delivery, U.S. manufacturing, FAA regulations and industry competition.

Who Will Control the Future of Driverless Cars?

Seth Goldstein, Senior Equity Analyst and Chair of the Electric Vehicle Committee at Morningstar, breaks down the robotaxi race and EV adoption trends.

Why the Next Space Revolution May Be About Power, Not Rockets

Andrew Rush, CEO of Star Catcher Industries, joins us to discuss how wireless power transmission could reshape satellite technology and space communications.

How Siri Is About to Get a Whole Lot Smarter

Apple unveils a smarter Siri and major AI updates. Mark Spoonauer, Global Editor-in-Chief at Tom’s Guide, breaks down WWDC 2026.

How to Build a Career That Survives the AI Revolution

As AI reshapes the workforce, author Benjamin Todd explains how graduates can build resilient, fulfilling careers and thrive in a changing job market.

The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare

America's GLP-1 boom is reshaping healthcare. SHARx co-founder Paul Pruitt explains who pays, why costs are surging, and what comes next.

Experian's AI Strategy Is Reshaping Financial Services

From Money 20/20, Experian UK & Ireland CEO Malin Holmberg discusses the trends, opportunities and innovations shaping fintech's future.

Big Business This Week: Decoding investor FOMO about the AI & SpaceX IPOs

A historic wave of IPOs is about to hit Wall Street. For the average investor watching from the sidelines, the frenzy can engender fears of missing out.

Load More